Biotechnology

Khiron Life Sciences Corp. to Present at the virtual Fall Investor Summit on November 16th-18th

November 12, 2020 9:35 AM

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Khiron Life Sciences Corp. ((TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt:A2JMZC)), a vertically integrated cannabis leader with core operations in Latin America and Europe, will be presenting at this year's virtual Fall Investor Summit on November 16th-18th. The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors. About Khiron Life...

Read more

ENDRA Life Sciences Inc. to Present at the virtual Fall Investor Summit on November 16th-18th

November 12, 2020 8:00 AM

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), The pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), will be presenting at this year's virtual Fall Investor Summit on November 16th-18th. The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors. About ENDRA Life Sciences Inc. ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA)...

Read more

Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab

November 11, 2020 4:20 PM

MONROVIA, CA, PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / November 11, 2020 / Xencor (XNCR), MorphoSys AG (FSE:MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:MOR) and Incyte (INCY) today announced a clinical collaboration to investigate the combination of tafasitamab, plamotamab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), first-line DLBCL, and relapsed or refractory follicular...

Read more

Milestone Scientific to Present at the Virtual Fall Investor Summit on November 18th

November 11, 2020 8:30 AM

ROSELAND, NJ / ACCESSWIRE / November 11, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the Virtual Fall Investor Summit to be held virtually on November 16-18, 2020. Leonard Osser, Interim Chief Executive Officer, is scheduled to present on Wednesday, November 18th at 9:30 a.m., Eastern Time. The...

Read more

American Screening Corporation Provides Extensive Range of Home Drug Testing Products

November 11, 2020 5:30 AM

SHREVEPORT, LA / ACCESSWIRE / November 11, 2020 / American Screening Corporation (ASC) began as an enterprise with a mission to provide high-quality drug and alcohol testing products. Over the years, the company has grown into a premier domestic and international ISO13485 contract manufacturer and distributor of diagnostic tests and essential medical supplies while also expanding its mission to support the fight against drug addiction and mental...

Read more

Applied UV, Inc. Announces Pricing of $6.4 Million Underwritten Public Offering

November 10, 2020 9:25 AM

MOUNT VERNON, NY / ACCESSWIRE / November 10, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its underwritten public offering of 1,219,048 shares of its common stock at a price of $5.25 per share. The Company expects to...

Read more

EV Biologics is Targeting Pink Current

November 10, 2020 8:30 AM

CHEYENNE, WY / ACCESSWIRE / November 10, 2020 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now current in its reporting showing a Yield sign. The Company targeted to become current in its reporting before the end of October and is pleased to have achieved its goal within the announced time frame. Being current now allows the majority of brokers to trade in our shares, whereas...

Read more

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

November 10, 2020 8:00 AM

BOSTON, MA / ACCESSWIRE / November 10, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences: Jefferies Virtual London Healthcare...

Read more

American Screening Corporation Enables Speedy and Efficient Decision-Making with Vast Selection of Rapid Drug Tests

November 9, 2020 7:00 PM

SHREVEPORT, LA / ACCESSWIRE / November 9, 2020 / Despite the social progress and economic prosperity achieved in the past few decades, certain issues remain a common challenge for nations worldwide. One of them is illicit drug use, which has been straining healthcare budgets, affecting workplace productivity, and endangering public safety. However, medical and technological advances have enabled government agencies, healthcare professionals,...

Read more

Helix BioPharma Corp. Signs Definitive Agreement to Fully Divest Polish Subsidiary

November 9, 2020 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / November 9, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced that it has signed a definitive share purchase agreement with CAIAC Fund Management AG ("CAIAC"), as designed trustee of HIO Fund (the "Fund"), to purchase Helix's...

Read more

Applied UV, Inc. Announces Non-Binding Letter of Intent to Acquire the Airocide(TM) System for Airborne Pathogen Reduction

November 9, 2020 3:15 PM

MOUNT VERNON, NY / ACCESSWIRE / November 9, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of ultra violet C ("UV-C") light utilizing its patented devices to destroy pathogens, including bacteria and viruses, safely, thoroughly, and automatically, today announced that in addition to its exclusive Joint Distribution and Licensing Agreement with Akida...

Read more

American Screening Corporation Offers Comprehensive Choice of Urine and Saliva Drug Tests

November 8, 2020 11:35 PM

SHREVEPORT, LA / ACCESSWIRE / November 8, 2020 / For close to 17 years, American Screening Corporation (ASC) has been supporting efforts to combat substance abuse and addiction by providing a vast array of drug testing products and striving to offer the best possible prices without compromising on quality. This has helped the Shreveport, Louisiana-based company become an ISO13485 contract manufacturer and one of the leading distributors of...

Read more

Edesa Biotech to Present at H.C. Wainwright & Co. 6th Annual Israel Conference

November 6, 2020 8:00 AM

TORONTO, ON / ACCESSWIRE / November 6, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to present at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020 at 12:30 pm ET. Edesa senior management will be available during the conference for one-on-one meetings. Members of the investment community who are interested...

Read more

Visioneering Technologies, Inc. to Present at the SNN Network Australia Virtual Event on Wednesday 11 November 2020 8:30 am Sydney Time (Tuesday 10 November at 4:30 pm New York Time)

November 5, 2020 7:40 PM

ATLANTA, GA / ACCESSWIRE / November 5, 2020 / Visioneering Technologies (ASX:VTI), US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc. is pleased to announce that it will be participating in the SNN Network Australia Virtual Event. The company presentation will be held on Wednesday 11 November 2020 at 8:30 am Sydney Time. Chief Executive Officer Dr....

Read more

Apollo Endosurgery, Inc. Reports Third Quarter 2020 Results

November 5, 2020 4:01 PM

Global Endoscopy Product Sales Increase 21% Year-Over-Year Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / November 5, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the third quarter ended September 30, 2020. Third Quarter 2020 and Recent...

Read more

Hancock Jaffe Announces Date for VenoValve Pre-IDE Meeting with FDA

November 5, 2020 1:45 PM

Meeting with FDA Set for December 22 IRVINE, CA / ACCESSWIRE / November 5, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Pre-IDE meeting with the U.S. Food and Drug Administration ("FDA") regarding the VenoValve U.S. pivotal trial has been set for December 22, 2020. Topics to be discussed at the December 22 virtual meeting with the...

Read more

Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Receipt of Additional Purchase Order for Airocide(TM) System From Hyatt Hotel's Dubai Creek Golf & Yacht Club Resort

November 5, 2020 8:13 AM

MOUNT VERNON, NY / ACCESSWIRE / November 5, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultraviolet light ("UVC") utilizing its patented devices to destroy pathogens, including bacteria and viruses safely, thoroughly, and automatically, today announced that its subsidiary, SteriLumen, Inc. ("SteriLumen"), together with Insightra Medical,...

Read more

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 6th Annual Israel Conference

November 5, 2020 8:05 AM

- Live video webcast with CEO, Jeffrey Eisenberg, on Tuesday, November 12th at 8:00 AM EST - FRAMINGHAM, MA / ACCESSWIRE / November 5, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic...

Read more

Lexaria Bioscience Advances 2021 Strategic Initiatives

November 5, 2020 6:45 AM

Lexaria Focusing on Four Core Business Segments: Heart disease including hypertension Reduced-risk non combusted nicotine Improved antiviral drug delivery CBD from hemp KELOWNA, BC / ACCESSWIRE / November 5, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in oral drug delivery platforms, is pleased to outline its planned strategic initiatives for 2021 with a sharply...

Read more

Applied UV, Inc. Announces Non-Binding Letter of Intent to Acquire the Airocide(TM) System for Airborne Pathogen Reduction

November 4, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / November 4, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of ultra violet C ("UV-C") light utilizing its patented devices to destroy pathogens, including bacteria and viruses, safely, thoroughly, and automatically, today announced that in addition to its exclusive Joint Distribution and Licensing Agreement with Akida...

Read more